With national healthcare spending expected to climb to 20 percent of U.S. GDP by 2025, the healthcare and life sciences sector will continue to play a dominant role in the marketplace for the foreseeable future. While extraordinary opportunities exist for businesses in the sector, significant risks—ranging from uncertainty over federal health policy, skyrocketing costs, and data breaches to increasing regulatory scrutiny of fraud, waste, and abuse—remain an ever-present concern.

Ranked Tier One in the United States in Healthcare Law by U.S. News – Best Lawyers, our Health and Life Sciences Sector Team provides comprehensive representation to medical device, pharmaceutical, and medical supply manufacturers and distributors; healthcare systems and providers; health insurers and managed care companies; and private equity firms and other sector-specific investors. Our team is bolstered by lawyers with industry knowledge gained from service as in-house counsel and senior executives at national health systems, biopharmaceutical companies, and state healthcare agencies. In addition, many of our lawyers have advanced technical degrees and business experience in fields such as chemistry and molecular biology, giving us additional insight into our clients’ business operations.

What We Do

To navigate our site
To search our site

Welcome to our new site

Click anywhere to enter